Aisling Capital

Aisling Capital is a private equity firm specializing in investments in product acquisitions, positioning companies in the public stock markets, follow-on financings, and industry consolidations. It invests in private and public healthcare companies, biopharmaceutical products, medical products, lifescience, companies with products in clinical development, therapeutics, and technologies and businesses that advance health and provide drug development, manufacturing and other important services to the healthcare industry. The firm typically invests between $20 million and $50 million or more in new capital. It usually participates in further rounds of financing following the initial investment. The firm prefers to be a lead or co-lead investor in its transactions. It seeks a board seat in its portfolio companies. Aisling Capital was founded in 2000 and is based at New York, New York.